G-361

Cat.No.: CSC-C9382L

Species: Homo sapiens (Human)

Source: Skin

Morphology: epithelial

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9382L
Description
Species: human - male, 31 years old, Caucasian
Isoenzyme: G6PD, B
Production: melanin
Histopathology: melanoma
Species
Homo sapiens (Human)
Source
Skin
Recommended Medium
Culture Properties
monolayer
Morphology
epithelial
STR DNA Profile
D3S1358: 16
vWA: 15,17
FGA: 19,21
Amelogenin: X
TH01: 7,9
TPOX: 8,10
CSF1P0: 10
D5S818: 11
D13S317: 11
D7S820: 8,11
Disease
Melanoma
Quality Control
Tests for mycoplasma, bacteria and fungi were negative
Storage and Shipping
Frozen with 52.5% RPMI-1640, 40% FBS, 7.5% DMSO at about 4-5 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
G361; G361-mel; G361mel
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The G-361 cell line was isolated from a metastatic skin lesion of a 31-year-old man with malignant melanoma. Morphologically, these are epithelioid, adherent cells with a highly malignant aspect, with irregular growth with proliferation under usual culture conditions. The G-361 cells are thought to have developed from melanocytes, which are epidermal pigment cells. In addition to a malignant appearance, they have the same oncogenic BRAF/NRAS mutations and melanoma-associated antigenic markers (e.g., S100, HMB-45). The G-361 cells have a high level of tyrosinase activity.

The cell line is commonly used in cancer biology to model and study the mechanisms of cancer progression, drug resistance, and metastasis. They can also be used to study the genetic and molecular basis of melanoma and its response to different targeted therapies, such as BRAF inhibitors and immunotherapies, as they also express melanoma-associated antigenic markers. In addition, the cells' consistent growth and phenotypic characteristics ensure reproducibility and reliability in experiments. The G-361 cell line is a frequently used in vitro model for many applications in basic and translational research to understand the biology of malignant melanoma, mechanisms of resistance to therapies, and the development of new therapeutic strategies.

Morphology of G-361 cells.

Fig. 1. Morphology of G-361 cells (Kozyra P, Korga-Plewko A, et al., 2022).

Cytotoxicity Effect of Simvastatin in G-361 Human Melanoma Cells

Free radicals in cancer cells can influence cancer processes and are affected by therapeutic substances. Chodurek et al. examined the influence of simvastatin at different concentrations on free radicals in G-361 human melanoma cells using EPR spectroscopy, aiming to correlate free radical changes with cell proliferation and find the optimal simvastatin concentration for cancer cell destruction.

To evaluate the cytotoxic activity of simvastatin, different concentrations of simvastatin (0.1-20 μM) were added to the medium and then the cells were cultured for 72 hours (Fig. 1). Simvastatin at a concentration of 0.1 μM, 0.3 μM, and 1 μM had no significant effect on the growth of cells compared to control cells. Treatment of G361 cells with 3 μM and 5 μM reduced cell growth, with similar cytotoxic activity. Cell growth inhibition was significant at 10 μM and 20 μM. IC50 value for G361 cells treated with simvastatin for 72 hours was 6.72 μM. In A-2058 melanoma cells, similar results were observed. Simvastatin had a more significant effect on the proliferation of A-375 cells. The morphological changes of G361 melanoma cells cultured with various simvastatin concentrations are presented in Fig. 2A-D. The cells cultured for 72 hours in medium with 1 μM simvastatin (Fig. 2B) did not show morphological changes in contrast to the controls (Fig. 2A), so they have good viability. On the other hand, the cells cultured in a medium with 20 μM simvastatin (Fig. 2D) have severe damage.

Cytotoxic effect of simvastatin on melanoma cells after 72 h of treatment.

Fig. 1. Cytotoxic effect of simvastatin on melanoma cells after 72 h of treatment (Chodurek E, Zdybel M, et al., 2025).

Morphology of G-631 human melanoma malignum.

Fig. 2. Morphology of G-631 human melanoma malignum (Chodurek E, Zdybel M, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products